share_log

Mainz Biomed Reported Revenue Of $0.52M For H1 2024, Up By 4% YoY, EPS Loss Of $(0.49)

Benzinga ·  Oct 21 20:06
Mainz Biomed Reported Revenue Of $0.52M For H1 2024, Up By 4% YoY, EPS Loss Of $(0.49)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment